Nes-GFP;iMLL-AF9 mice sacrificed 8–10 weeks after AML induction showed a significant reduction in the number of BM CD45−Ter119−CD31− stromal cells, compared with disease-free controls (Figure 1G). This evidence concerns the gene MLLT3 and acute myeloid leukemia.